This issue's research highlight is the role of long non-coding RNA (lncRNA) in cardiovascular diseases. Research shows that lncRNA is closely linked to various cardiovascular conditions and has potential as a biomarker.

This issue examines the multifaceted impacts and clinical challenges of cardiovascular health, highlighting the necessity of considering diverse factors in treatment strategies. This research provides new perspectives for the future of cardiovascular health.

Cardiac rehabilitation interventions are becoming increasingly diverse. This issue focuses on a multidimensional research perspective, showcasing the potential of innovative methods in improving heart health and recovery outcomes.

Cardiovascular pharmacological interventions are crucial for disease treatment. This issue explores innovative findings related to enhancing blood circulation and improving cardiac function through pharmacological agents, thereby opening new avenues for cardiovascular therapy.

The COVID-19 pandemic may lead to cardiovascular pathological manifestations, necessitating a high level of vigilance for all affected patients. This issue's highlights focus on elucidating the pathophysiology of COVID-19 infection and its impact on cardiovascular patients to improve outcomes for those affected.

The theme of this issue is the risk assessment of cardiovascular diseases, analyzing the susceptibility to cardiovascular disease among different populations and regions to provide important evidence for formulating effective prevention strategies and improving patient outcomes.

In recent years, cardiovascular disease research has deepened its focus on the advancements of multiple factors, revealing their profound impact on disease mechanisms and treatment outcomes.